JournalsHub
.online
Find My Journal
RG

Roland Goldbrunner

University Hospital Cologne DE

ORCID 0000-0002-1927-0022
582
Publications
15,642
Citations
55
H-Index
191
i10-Index
3.24
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

572 total

EANO guideline on the diagnosis and management of meningiomas PDF

Roland Goldbrunner, Pantelis Stavrinou, Michael D. Jenkinson, Felix Sahm, Christian Mawrin et al. - Neuro-Oncology, 2021
Cited by 673 OpenAlex

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial PDF

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, Joachim P. Steinbach, Uwe Schlegel et al. - The Lancet, 2019
Cited by 569 OpenAlex

EANO guideline on the diagnosis and treatment of vestibular schwannoma PDF

Roland Goldbrunner, Michael Weller, Jean Régis, Morten Lund‐Johansen, Pantelis Stavrinou et al. - Neuro-Oncology, 2019
Cited by 419 OpenAlex

Correction: Author Correction: Integrated genomic analyses of de novo pathways underlying atypical meningiomas PDF

Akdes Serin Harmancı, Mark W. Youngblood, Victoria Clark, Süleyman Coşkun, Octavian Henegariu et al. - Nature Communications, 2018
Cited by 908 OpenAlex

EANO guidelines for the diagnosis and treatment of meningiomas PDF

Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D. Jenkinson, Kita Sallabanda et al. - The Lancet Oncology, 2016
Cited by 838 OpenAlex

Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas PDF

Victoria Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W. Youngblood, Tong Ihn Lee et al. - Nature Genetics, 2016
Cited by 350 OpenAlex

<i>MGMT</i> Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial PDF

Michael Weller, Ghazaleh Tabatabai, Bärbel Kästner, Jörg Felsberg, Joachim P. Steinbach et al. - Clinical Cancer Research, 2015
Cited by 315 OpenAlex

Reprogramming of Pericyte-Derived Cells of the Adult Human Brain into Induced Neuronal Cells PDF

Marisa Karow, Rodrigo Sánchez, Christian Schichor, Giacomo Masserdotti, Felipe Ortega et al. - Cell stem cell, 2012
Cited by 300 OpenAlex

Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma PDF

Roger Stupp, Monika E. Hegi, Bart Neyns, Roland Goldbrunner, Uwe Schlegel et al. - Journal of Clinical Oncology, 2010
Cited by 443 OpenAlex

Spontaneous Malignant Transformation of Human Mesenchymal Stem Cells Reflects Cross-Contamination: Putting the Research Field on Track – Letter PDF

Anja Torsvik, Gro Vatne Røsland, Agnete Svendsen, Anders Molven, Heike Immervoll et al. - Cancer Research, 2010
Cited by 283 OpenAlex

Research Topics

Glioma Diagnosis and Treatment (224) Meningioma and schwannoma management (101) Brain Metastases and Treatment (78) Radiomics and Machine Learning in Medical Imaging (47) Cancer, Hypoxia, and Metabolism (34)

Affiliations

Goethe University Frankfurt
DE 2016 - 2010
United States Nuclear Regulatory Commission
US 2015 - 2015
Centre National de la Recherche Scientifique
FR 2013 - 2013
Innsbruck Medical University
AT 2009 - 2009
Max Planck Society
DE 2008 - 2008

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now